Výsledky vyhledávání

Ehlers–Danlos syndrome: case report and an electron microscopy study

Autor: Maria Rosaria Torrisi, F. Turturro, A. Gamba, Marta Carlesimo, G. Cortesi, Salvatore Raffa, Alessandra Narcisi, G. Camplone

Publikováno v: Rheumatology International. 32:1507-1510

Ehlers-Danlos syndrome (EDS) type III is a inherited connective tissue disorders characterized by extensibility of the skin, hypermobility of the joints, chronic pain, tissue fragility, easy bruising, and delayed wound healing with result of atrophic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e9ad73e83bcaa375f9778dac6be6c0
https://doi.org/10.1007/s00296-010-1778-6

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Apolipoprotein C-II deficiency: detection of immunoreactive apolipoprotein C-II in the intestinal mucosa of two patients

Autor: A Capurso, A M Mogavero, F Resta, M Di Tommaso, P Taverniti, F Turturro, M La Rosa, S Marcovina, A L Catapano

Publikováno v: Journal of Lipid Research, Vol 29, Iss 6, Pp 703-711 (1988)

Recent data suggest that mutant immunoreactive forms of apolipoprotein C-II (apoC-II) can be detected in the plasma of patients with the apoC-II deficiency syndrome. We studied the possible presence of apoC-II mutants in the plasma of two patients wi

Externí odkaz: https://doaj.org/article/9cbe091a9e9f423aa4e906a64f35064f

Zobrazit plný text záznamu

The emerging normal and disease-related roles of anaplastic lymphoma kinase

Autor: K, Pulford, L, Lamant, E, Espinos, Q, Jiang, L, Xue, F, Turturro, G, Delsol, S W, Morris

Publikováno v: Cellular and molecular life sciences : CMLS. 61(23)

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase, the normal role of which remains to be completely elucidated. Although work carried out in mammals suggests a function in neural development, results from studies in Drosophila indicate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::857bc24fd55fac19c0aeda8548aa8dc9
https://pubmed.ncbi.nlm.nih.gov/15583856

Zobrazit plný text záznamu

In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma

Autor: F, Turturro, P, Seth, C J, Link

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 6(1)

Adenoviral vector-mediated p53 expression induced apoptosis is a well established gene therapy approach that has been evaluated extensively in epithelial tumors but only recently in lymphoid malignancies mainly due to the known resistance of the lymp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e56d91615c06a2dc36e42d3b892d19cb
https://pubmed.ncbi.nlm.nih.gov/10656449

Zobrazit plný text záznamu

Consolidation therapy with yttrium-90-ibritumomab tiuxetan in follicular lymphoma following induction with modern chemoimmunotherapy regimens: A single-institution experience

Autor: Runhua Shi, Z. Yang, Nebu Koshy, J. Angelo, Glenn Mills, Binu Nair, F. Turturro

Publikováno v: Journal of Clinical Oncology. 29:e18553-e18553

e18553 Background: Radioimmunotherapy (RIT) remains underused in the U.S and other countries despite many studies documenting the important therapeutic role it can play in the management of many B-...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::98c59eefc0a335a254c76d06971a97a5
https://doi.org/10.1200/jco.2011.29.15_suppl.e18553

Zobrazit plný text záznamu

Voreloxin single-agent treatment of older patients (60 years or older) with previously untreated acute myeloid leukemia: Final results from a phase II study with three schedules

Autor: Michael B. Maris, Robert K. Stuart, Glenn Michelson, F. Turturro, Richard Stone, Judith A. Fox, Larry D. Cripe, F. Ravandi Kashani, Maureen Cooper, Shaker R. Dakhil

Publikováno v: Journal of Clinical Oncology. 28:6525-6525

6525 Background: Voreloxin, an anticancer quinolone derivative that inhibits topoisomerase II, has demonstrated clinical activity in ovarian cancer and acute myeloid leukemia (AML). Final results a...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e73fcaeae9ddd7d841665e439b9f107e
https://doi.org/10.1200/jco.2010.28.15_suppl.6525

Zobrazit plný text záznamu

A phase II study of voreloxin as single agent therapy for elderly patients (pts) with newly diagnosed acute myeloid leukemia (AML)

Autor: Larry D. Cripe, Robert K. Stuart, Wendy Stock, Stephen A. Strickland, C. Berman, F. Turturro, Michael B. Maris, Richard Stone, Maureen Cooper, Farhad Ravandi

Publikováno v: Journal of Clinical Oncology. 27:7048-7048

7048 Background: Voreloxin is a naphthyridine analog that intercalates DNA and inhibits topoisomerase II, inducing apoptosis. Interim results of REVEAL-1, a phase II study of single agent voreloxin in newly diagnosed elderly AML pts, are reported. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9f14b3467c116c820ce27a7abfa81f1
https://doi.org/10.1200/jco.2009.27.15_suppl.7048

Zobrazit plný text záznamu

A phase II study of denileukin diftitox (ONTAK) in patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

Autor: Philip Kuriakose, A. Surendranathan, F. Turturro, R. Kerr, Arthur E. Frankel, J. Berdeja, J. Black, M. Lilly

Publikováno v: Journal of Clinical Oncology. 23:6649-6649

6649 Background: Some chronic lymphocytic leukemia (CLL) cells express CD25, a component of the IL-2 receptor. Denileukin diftitox (ONTAK, Ligand Pharmaceuticals) is a fusion protein of the enzymat...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d53f4c667b09090ebb70d63c859d375
https://doi.org/10.1200/jco.2005.23.16_suppl.6649

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání